Dr. Knowlton has won numerous awards for his leadership in pharmacy, business, and philanthropy in his career of over 40 years, including the 2003 & 2013 Ernest and Young Entrepreneur of the Year Award, Greater Philadelphia Region, and the 2016 Philadelphia Technology CEO of the year. He served as the national President for the American College of Apothecaries, President of the American Pharmacists Association for two terms, and President of the American Pharmacists Association Foundation. In 2015, Knowlton was awarded the Remington Honor Medal, pharmacy’s highest honor.
Board service includes: Chair of the Board of the Evergreens Continuing Care Retirement Community; Founding Board member of the Cooper Medical School of Rowan University; member of the Boards for The Coriell Institute for Medical Research, St Christopher’s Hospital for Children, the Settlement Music School, Samaritan Hospice & Palliative Care, and Spyglass II condominium board in Amelia Island.
Dr. Knowlton is co-Founder, Chairperson and CEO of Tabula Rasa HealthCare (TRHC), the first national Medication Risk Mitigation™ Company. Since its founding in 2009, TRHC has become the leader in providing patient-specific, data- driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. He took TRHC public in September, 2016 (NASDAQ: TRHC). The Company now employees >1,500 team members, with more than 400 Board Certified PharmDs.
Dr. Knowlton received his pharmacy degree from Temple University, Divinity degree from Princeton Theological Seminary, PhD in pharmacoeconomics from the University of Maryland, and Doctor of Science (ScD) from the University of Maryland. He served as Professor and Department Chair for the University of the Sciences in Philadelphia in the 1990s.